Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Drazen

Showing results (51-60 of 329) with videos related to

Pageof 33
Sort By:
The American Review of Respiratory Disease|March 1, 1991
Airway luminal liquid. Sources and role as an amplifier of bronchoconstrictionD Yager, S Shore, J M Drazen
Drug Safety|October 8, 1999
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?M E Wechsler, R Pauwels, J M Drazen
Thorax|November 1, 1996
Beta 2 adrenoceptor polymorphismsJ M Drazen, S T Weiss, D Cooper
The New England Journal of Medicine|October 19, 2000
The Republican and Democratic candidates speak on health careJ M Drazen, G W Bush, A Gore
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1987
Differential effects of calcium channel blockers on leukotriene C4- and D4-induced contractions in guinea pig pulmonary parenchymal stripsE Israel, J L Robin, J M Drazen
Annual Review of Physiology|January 1, 1995
Chemical regulation of pulmonary airway toneJ M Drazen, B Gaston, S A Shore
Annals of Internal Medicine|October 6, 1997
Antileukotrienes in the treatment of asthmaP M O'Byrne, E Israel, J M Drazen
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 21, 2000
Neuronal NO synthase (NOS1) is a major candidate gene for asthmaH Grasemann, C N Yandava, J M Drazen
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
Human lung expresses unique gamma-glutamyl transpeptidase transcriptsL A Wetmore, C Gerard, J M Drazen
The New England Journal of Medicine|January 23, 1999
Treatment of asthma with drugs modifying the leukotriene pathwayJ M Drazen, E Israel, P M O'Byrne
Pageof 33

Showing results (51-60 of 329) with videos related to

Sort By:
Pageof 33
The American Review of Respiratory Disease|March 1, 1991
Airway luminal liquid. Sources and role as an amplifier of bronchoconstrictionD Yager, S Shore, J M Drazen
Drug Safety|October 8, 1999
Leukotriene modifiers and Churg-Strauss syndrome: adverse effect or response to corticosteroid withdrawal?M E Wechsler, R Pauwels, J M Drazen
Thorax|November 1, 1996
Beta 2 adrenoceptor polymorphismsJ M Drazen, S T Weiss, D Cooper
The New England Journal of Medicine|October 19, 2000
The Republican and Democratic candidates speak on health careJ M Drazen, G W Bush, A Gore
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1987
Differential effects of calcium channel blockers on leukotriene C4- and D4-induced contractions in guinea pig pulmonary parenchymal stripsE Israel, J L Robin, J M Drazen
Annual Review of Physiology|January 1, 1995
Chemical regulation of pulmonary airway toneJ M Drazen, B Gaston, S A Shore
Annals of Internal Medicine|October 6, 1997
Antileukotrienes in the treatment of asthmaP M O'Byrne, E Israel, J M Drazen
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 21, 2000
Neuronal NO synthase (NOS1) is a major candidate gene for asthmaH Grasemann, C N Yandava, J M Drazen
Proceedings of the National Academy of Sciences of the United States of America|August 15, 1993
Human lung expresses unique gamma-glutamyl transpeptidase transcriptsL A Wetmore, C Gerard, J M Drazen
The New England Journal of Medicine|January 23, 1999
Treatment of asthma with drugs modifying the leukotriene pathwayJ M Drazen, E Israel, P M O'Byrne
Pageof 33